• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SCN5A 基因 M1875T 突变导致家族性心房颤动,增加早期钠电流并减弱氟卡尼的作用。

Familial atrial fibrillation mutation M1875T-SCN5A increases early sodium current and dampens the effect of flecainide.

机构信息

Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston, Wolfson Drive, Birmingham B15 2TT, UK.

Department of Experimental Cardiology, Academic Medical Center, Amsterdam, The Netherlands.

出版信息

Europace. 2023 Mar 30;25(3):1152-1161. doi: 10.1093/europace/euac218.

DOI:10.1093/europace/euac218
PMID:36504385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10062360/
Abstract

AIMS

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Pathogenic variants in genes encoding ion channels are associated with familial AF. The point mutation M1875T in the SCN5A gene, which encodes the α-subunit of the cardiac sodium channel Nav1.5, has been associated with increased atrial excitability and familial AF in patients.

METHODS AND RESULTS

We designed a new murine model carrying the Scn5a-M1875T mutation enabling us to study the effects of the Nav1.5 mutation in detail in vivo and in vitro using patch clamp and microelectrode recording of atrial cardiomyocytes, optical mapping, electrocardiogram, echocardiography, gravimetry, histology, and biochemistry. Atrial cardiomyocytes from newly generated adult Scn5a-M1875T+/- mice showed a selective increase in the early (peak) cardiac sodium current, larger action potential amplitude, and a faster peak upstroke velocity. Conduction slowing caused by the sodium channel blocker flecainide was less pronounced in Scn5a-M1875T+/- compared to wildtype atria. Overt hypertrophy or heart failure in Scn5a-M1875T+/- mice could be excluded.

CONCLUSION

The Scn5a-M1875T point mutation causes gain-of-function of the cardiac sodium channel. Our results suggest increased atrial peak sodium current as a potential trigger for increased atrial excitability.

摘要

目的

心房颤动(AF)是最常见的心律失常。编码离子通道的基因中的致病变体与家族性 AF 有关。SCN5A 基因编码心脏钠离子通道 Nav1.5 的α亚基,其点突变 M1875T 与增加的心房兴奋性和家族性 AF 有关在患者中。

方法和结果

我们设计了一种携带 Scn5a-M1875T 突变的新型小鼠模型,使我们能够使用膜片钳和心房肌细胞的微电极记录、光学映射、心电图、超声心动图、称重、组织学和生物化学等方法在体内和体外详细研究 Nav1.5 突变的影响。新产生的成年 Scn5a-M1875T+/- 小鼠的心房肌细胞表现出早期(峰值)心脏钠离子电流的选择性增加、更大的动作电位幅度和更快的峰值上升速度。与野生型心房相比,钠通道阻滞剂 flecainide 引起的传导减慢在 Scn5a-M1875T+/- 中不那么明显。可以排除 Scn5a-M1875T+/- 小鼠明显的肥大或心力衰竭。

结论

Scn5a-M1875T 点突变导致心脏钠离子通道功能获得。我们的结果表明增加的心房峰值钠离子电流可能是增加心房兴奋性的潜在触发因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7d/10062360/9be4a42e13f6/euac218f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7d/10062360/a8f7b8e44077/euac218_ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7d/10062360/a9464cb62bea/euac218f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7d/10062360/663f3a0233e1/euac218f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7d/10062360/b955e7d5ad35/euac218f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7d/10062360/0d31447be9da/euac218f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7d/10062360/9be4a42e13f6/euac218f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7d/10062360/a8f7b8e44077/euac218_ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7d/10062360/a9464cb62bea/euac218f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7d/10062360/663f3a0233e1/euac218f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7d/10062360/b955e7d5ad35/euac218f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7d/10062360/0d31447be9da/euac218f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7d/10062360/9be4a42e13f6/euac218f5.jpg

相似文献

1
Familial atrial fibrillation mutation M1875T-SCN5A increases early sodium current and dampens the effect of flecainide.SCN5A 基因 M1875T 突变导致家族性心房颤动,增加早期钠电流并减弱氟卡尼的作用。
Europace. 2023 Mar 30;25(3):1152-1161. doi: 10.1093/europace/euac218.
2
A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation.钠通道中的一种突变是长QT综合征与家族性心房颤动之间关联的原因。
Heart Rhythm. 2008 Oct;5(10):1434-40. doi: 10.1016/j.hrthm.2008.07.013. Epub 2008 Jul 19.
3
Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.点突变致功能获得性钠通道突变可延长心房动作电位并改变心房易损性。
Heart Rhythm. 2010 Dec;7(12):1862-9. doi: 10.1016/j.hrthm.2010.08.016. Epub 2010 Aug 19.
4
Gain-of-function mutation in SCN5A causes ventricular arrhythmias and early onset atrial fibrillation.SCN5A功能获得性突变导致室性心律失常和早发性心房颤动。
Int J Cardiol. 2017 Jun 1;236:187-193. doi: 10.1016/j.ijcard.2017.01.113. Epub 2017 Jan 29.
5
Exploring SCN5A variants associated with atrial fibrillation in atrial cardiomyocytes derived from human induced pluripotent stem cells: A characterization study.探索源自人类诱导多能干细胞的心房心肌细胞中与心房颤动相关的SCN5A变体:一项特征研究。
Heart Rhythm. 2025 Jun;22(6):1574-1587. doi: 10.1016/j.hrthm.2024.09.013. Epub 2024 Sep 10.
6
Human induced pluripotent stem cell-derived atrial cardiomyocytes carrying an SCN5A mutation identify nitric oxide signaling as a mediator of atrial fibrillation.人诱导多能干细胞源性心房肌细胞携带 SCN5A 突变,确定一氧化氮信号作为心房颤动的介质。
Stem Cell Reports. 2021 Jun 8;16(6):1542-1554. doi: 10.1016/j.stemcr.2021.04.019. Epub 2021 May 20.
7
A truncating SCN5A mutation combined with genetic variability causes sick sinus syndrome and early atrial fibrillation.一种截短型SCN5A突变与基因变异性相结合导致病态窦房结综合征和早期房颤。
Heart Rhythm. 2014 Jun;11(6):1015-1023. doi: 10.1016/j.hrthm.2014.02.021. Epub 2014 Feb 25.
8
Cardiac sodium channel mutation in atrial fibrillation.心房颤动中的心脏钠通道突变。
Heart Rhythm. 2008 Jan;5(1):99-105. doi: 10.1016/j.hrthm.2007.09.015. Epub 2007 Sep 19.
9
Loss of Nav1.5 expression and function in murine atria containing the RyR2-P2328S gain-of-function mutation.在含有 RyR2-P2328S 功能获得性突变的小鼠心房中,Nav1.5 的表达和功能丧失。
Cardiovasc Res. 2013 Sep 1;99(4):751-9. doi: 10.1093/cvr/cvt141. Epub 2013 May 30.
10
Anti-arrhythmic potential of the late sodium current inhibitor GS-458967 in murine Scn5a-1798insD+/- and human SCN5A-1795insD+/- iPSC-derived cardiomyocytes.GS-458967 对晚期钠电流抑制剂在 Scn5a-1798insD+/- 小鼠和 SCN5A-1795insD+/- 人类 iPSC 衍生心肌细胞中的抗心律失常作用。
Cardiovasc Res. 2017 Jun 1;113(7):829-838. doi: 10.1093/cvr/cvx077.

引用本文的文献

1
LncRNA Dleu2 Serve as a Novel Biomarker for Ablation Recurrence and Promote Atrial Remodelling by Targeting Nr4a1 in Atrial Fibrillation.长链非编码RNA Dleu2作为消融复发的新型生物标志物,并通过靶向Nr4a1促进心房颤动中的心房重构。
J Cell Mol Med. 2025 Jun;29(11):e70618. doi: 10.1111/jcmm.70618.
2
The Genetic Mechanisms and Pathology of Atrial Fibrillation: A Narrative Review.心房颤动的遗传机制与病理学:一篇叙述性综述
Biomedicines. 2025 Mar 7;13(3):654. doi: 10.3390/biomedicines13030654.
3
Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting Na1.5, K1.5, and KP channels for atrial fibrillation.

本文引用的文献

1
Increased atrial effectiveness of flecainide conferred by altered biophysical properties of sodium channels.通道生物物理特性改变赋予氟卡尼增强的心房效能。
J Mol Cell Cardiol. 2022 May;166:23-35. doi: 10.1016/j.yjmcc.2022.01.009. Epub 2022 Feb 1.
2
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes.早发性心房颤动与心肌病和心律失常基因罕见变异的患病率。
JAMA Cardiol. 2021 Dec 1;6(12):1371-1379. doi: 10.1001/jamacardio.2021.3370.
3
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference.
针对心房颤动,合理设计、合成及评估靶向Na1.5、K1.5和KP通道的新型多靶点药物化合物。
J Biol Chem. 2025 Apr;301(4):108387. doi: 10.1016/j.jbc.2025.108387. Epub 2025 Mar 5.
4
Pediatric flecainide pharmacogenomics: a roadmap to delivering precision-based care to pediatrics arrhythmias.小儿氟卡尼药物基因组学:为小儿心律失常提供精准医疗的路线图。
Front Pharmacol. 2024 Dec 16;15:1477485. doi: 10.3389/fphar.2024.1477485. eCollection 2024.
5
Identification and Functional Investigation of as a Novel Gene Underpinning Familial Atrial Fibrillation.作为家族性心房颤动潜在新基因的鉴定与功能研究。
Diagnostics (Basel). 2024 Oct 25;14(21):2376. doi: 10.3390/diagnostics14212376.
6
Optical mapping and optogenetics in cardiac electrophysiology research and therapy: a state-of-the-art review.光学绘图与光遗传学在心脏电生理学研究与治疗中的应用:最新综述。
Europace. 2024 Feb 1;26(2). doi: 10.1093/europace/euae017.
7
25 years of basic and translational science in EP Europace: novel insights into arrhythmia mechanisms and therapeutic strategies.25 年的 EP Europace 基础与转化科学:心律失常机制和治疗策略的新见解。
Europace. 2023 Aug 25;25(8). doi: 10.1093/europace/euad210.
8
The opioid tramadol blocks the cardiac sodium channel Nav1.5 in HEK293 cells.阿片类药物曲马多在 HEK293 细胞中阻断心脏钠离子通道 Nav1.5。
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad209.
9
Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.慢性美西律治疗 SCN5A 重叠综合征患者的有益作用。
Europace. 2023 Jun 2;25(6). doi: 10.1093/europace/euad154.
10
Genetics of sinoatrial node function and heart rate disorders.窦房结功能和心率失常的遗传学。
Dis Model Mech. 2023 May 1;16(5). doi: 10.1242/dmm.050101. Epub 2023 May 17.
动态风险评估改善心房颤动患者的护理质量:第 7 次 AFNET/EHRA 共识会议。
Europace. 2021 Mar 8;23(3):329-344. doi: 10.1093/europace/euaa279.
4
Structural basis of cytoplasmic NaV1.5 and NaV1.4 regulation.细胞质钠通道 NaV1.5 和 NaV1.4 调节的结构基础。
J Gen Physiol. 2021 Jan 4;153(1). doi: 10.1085/jgp.202012722.
5
JavaCyte, a novel open-source tool for automated quantification of key hallmarks of cardiac structural remodeling.JavaCyte,一种用于自动量化心脏结构重构关键特征的新型开源工具。
Sci Rep. 2020 Nov 18;10(1):20074. doi: 10.1038/s41598-020-76932-3.
6
Pervasive head-to-tail insertions of DNA templates mask desired CRISPR-Cas9-mediated genome editing events.普遍存在的 DNA 模板从头至尾插入会掩盖所需的 CRISPR-Cas9 介导的基因组编辑事件。
Sci Adv. 2020 Feb 12;6(7):eaax2941. doi: 10.1126/sciadv.aax2941. eCollection 2020 Feb.
7
ElectroMap: High-throughput open-source software for analysis and mapping of cardiac electrophysiology.ElectroMap:高通量开源软件,用于心脏电生理学的分析和映射。
Sci Rep. 2019 Feb 4;9(1):1389. doi: 10.1038/s41598-018-38263-2.
8
Predicting changes to I from missense mutations in human SCN5A.预测人类 SCN5A 错义突变对 I 的影响。
Sci Rep. 2018 Aug 24;8(1):12797. doi: 10.1038/s41598-018-30577-5.
9
The VAMP-associated protein VAPB is required for cardiac and neuronal pacemaker channel function.VAMP 相关蛋白 VAPB 是心脏和神经元起搏通道功能所必需的。
FASEB J. 2018 Nov;32(11):6159-6173. doi: 10.1096/fj.201800246R. Epub 2018 Jun 7.
10
A Regional Reduction in Ito and IKACh in the Murine Posterior Left Atrial Myocardium Is Associated with Action Potential Prolongation and Increased Ectopic Activity.小鼠左心房后壁心肌中Ito和IKACh的区域性降低与动作电位延长和异位活动增加有关。
PLoS One. 2016 May 5;11(5):e0154077. doi: 10.1371/journal.pone.0154077. eCollection 2016.